BYSI, PHUN and DTSS among pre-market losers
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 06 2024
0mins
Should l Buy ODD?
Source: SeekingAlpha
- Losers: Several companies experienced stock price declines after Q4 earnings releases, including Entravision Communications Corp., Thor Industries, BeyondSpring, ODDITY Tech Ltd., Phunware, Foot Locker, Nordstrom, Grifols, Zhongchao, Datasea, China Jo-Jo Drugstores, Ainos, Vanda Pharmaceuticals, Roma Green Finance Limited, Winnebago Industries, CASI Pharmaceuticals, Renalytix, Adial Pharmaceuticals, ChargePoint Holdings, and Xeris Biopharma Holdings.
- Datasea: Datasea's stock jumped 23% due to a potential $30M sale agreement by its subsidiary.
- BeyondSpring: Seeking Alpha provided a Quant Rating on BeyondSpring, and there was historical earnings data available for the company.
- BeyondSpring: Financial information was available for BeyondSpring.
- Datasea: Financial information was available for Datasea.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ODD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ODD
Wall Street analysts forecast ODD stock price to rise
8 Analyst Rating
6 Buy
2 Hold
0 Sell
Strong Buy
Current: 29.900
Low
49.00
Averages
66.63
High
80.00
Current: 29.900
Low
49.00
Averages
66.63
High
80.00
About ODD
Oddity Tech Ltd is an Israel-based company engaged in the beauty and wellness sector on the molecular level. The Company is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The Company is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The Company is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Announcement Schedule: Oddity Tech is set to release its Q4 earnings on February 25 before market open, with consensus EPS estimate at $0.14, reflecting a 30% year-over-year decline, while revenue is expected to reach $151.08 million, indicating a 22.2% year-over-year growth, showcasing the company's revenue growth potential.
- Performance Consistency: Over the past two years, Oddity Tech has consistently beaten EPS and revenue estimates 100% of the time, which not only boosts market confidence but also provides investors with a stable earnings outlook.
- Analyst Rating Support: Oddity Tech is recognized as a top SMID core idea by Evercore ISI, indicating a positive market sentiment towards its future performance and further solidifying its appeal among investors.
- Estimate Revision Trends: In the last three months, Oddity Tech's EPS estimates have seen one upward revision with no downward adjustments, reflecting analysts' confidence in the company's future profitability, which could positively impact its stock price.
See More
- Investment Recommendation: Evercore ISI has added Oddity Tech Ltd. (ODD) to its list of best SMID Core Idea stock picks for 2026, citing the company's strong fundamentals and high-retention subscription model that demonstrates consistent cash generation capabilities.
- Revenue Growth Potential: Analyst Mark Mahaney highlighted that approximately two-thirds of Oddity Tech's revenue comes from repeat customers, indicating a defensive growth profile, with core brands expected to continue delivering double-digit growth, supporting future revenue increases.
- Attractive Valuation: Oddity Tech currently trades at 7X EV/EBITDA and 15X P/E, which is considered attractive relative to peers, potentially drawing more investor interest.
- Market Performance: Despite Oddity Tech's shares being down 18.0% year-to-date, the strong brand momentum and an upcoming major product cycle provide a favorable risk-reward outlook for investors.
See More

- Oversold Stock Overview: In the consumer staples sector, ODDITY Tech, PMGC Holdings, and Zevia have relative strength indices (RSI) below 30, at 25.3, 16.2, and 26 respectively, indicating these stocks are significantly undervalued and may present buying opportunities for investors.
- ODDITY Tech Rating Adjustment: Keybanc analyst maintained an Overweight rating on ODDITY Tech but lowered the price target from $70 to $50, reflecting market caution regarding its future performance, despite its stock price falling approximately 20% over the past month.
- PMGC Holdings Reverse Split: PMGC Holdings announced a 1-for-4 reverse split and invested in non-controlling shares of Nuclea Energy; however, its stock plummeted 73% over the past month, currently at a 52-week low of $3.54 with an RSI of 16.2.
- Zevia Stock Performance: Telsey Advisory Group analyst maintained an Outperform rating for Zevia with a price target of $6, even as its stock fell 33% over the past month to a 52-week low of $1.66, with an RSI of 26 indicating potential for a rebound.
See More
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
See More

- Data-Driven Growth: Oddity Tech has enhanced customer loyalty through its direct-to-consumer platform by leveraging data analytics, resulting in higher repeat purchase rates and increased shareholder value.
- Launch of Methodiq Platform: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing personalized treatment solutions for tens of millions of Americans suffering from skin conditions, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI-powered skin analysis and computer vision technology, catering to diverse user needs and further expanding market share.
- Strategic Investment Outlook: With the launch of Methodiq, Oddity Tech is poised to attract more consumers willing to pay premium prices for beauty products, unlocking substantial growth opportunities and driving future shareholder returns.
See More
- Market Potential: Oddity's addressable market is vast, as the beauty and wellness industry largely operates on an old-economy model, while Oddity's tech-driven e-commerce approach shows strong growth potential.
- Customer Loyalty Boost: By leveraging user data, Oddity has rapidly increased customer loyalty with impressive repeat purchase rates, thereby enhancing the company's competitive edge and shareholder value.
- New Platform Launch: In November 2025, Oddity launched the Methodiq telehealth platform aimed at providing effective treatments for dermatological issues to tens of millions of Americans, which is expected to significantly enhance the company's long-term growth potential.
- Product Diversification: Methodiq will offer over 100 personalized treatment plans utilizing AI technology and proprietary ingredients from Oddity Labs, catering to diverse user needs and further expanding Oddity's market share.
See More








